Infinity Announces Key 2010 Objectives
January 11, 2010 09:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today provided guidance on its...
Infinity Announces Updated Presentation Time at the J.P. Morgan Healthcare Conference
January 11, 2010 08:43 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the company has an...
Infinity Announces Presentations at January Conferences
January 07, 2010 15:32 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Jan. 7, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that presentations will be...
Infinity Names Adelene Q. Perkins Chief Executive Officer
December 07, 2009 06:30 ET
|
Infinity Pharmaceuticals, Inc.
Steven H. Holtzman to Serve as Executive Chair of the Board of
Directors in Accordance With Existing Succession Plan
Transition Strategically Positions Infinity for the...
Infinity's IPI-504 Named One of Windhover and Campbell Alliance's "Top 10 Projects to Watch" in Oncology
November 17, 2009 08:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Nov. 17, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Jeffrey Tong, Ph.D.,...
Adelene Q. Perkins Named "Best Executive" at Annual Stevie(R) Awards Ceremony
November 16, 2009 09:30 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Nov. 16, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Adelene Q. Perkins,...
Infinity to Present at Upcoming Conferences
November 10, 2009 07:30 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Nov. 10, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will...
Infinity Reports Recent R&D Highlights and Third Quarter 2009 Results
November 09, 2009 16:00 ET
|
Infinity Pharmaceuticals, Inc.
-- Enrollment Open in All of Infinity's Ongoing Hsp90 Chaperone
Inhibitor Studies
-- Infinity Maintains Financial Strength to Advance Its Innovative
Product Pipeline
CAMBRIDGE,...
Infinity Announces Third Quarter 2009 Results Conference Call
November 02, 2009 06:30 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Nov. 2, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced today that management will host...
Infinity Announces Appointment of Dr. Thomas J. Lynch to Its Board of Directors
October 07, 2009 07:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Oct. 7, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced today that Thomas J. Lynch, Jr.,...